Scholar Rock Holding (SRRK) Accounts Payables (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly Accounts Payables came in at $9.2 million in Q1 2026, up 107.75% year-on-year from $4.4 million in Q1 2025, and down 10.53% quarter-over-quarter from $10.3 million in Q4 2025.
Scholar Rock Holding (SRRK) Accounts Payables (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Accounts Payables history runs 10 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- On a quarterly basis, Accounts Payables rose 107.75% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $9.2 million, a 107.75% increase from a year earlier, with the FY2025 full-year figure at $10.3 million, up 2.06% from the prior year.
- Accounts Payables declined to $9.2 million in Q1 2026 per SRRK's latest filing, from $10.3 million in the prior quarter.
- Across five years, Accounts Payables topped out at $10.3 million in Q4 2025 and bottomed at $1.1 million in Q2 2025.
- The 5-year median for Accounts Payables is $3.5 million (2023), against an average of $4.5 million.
- Across the five-year window, Accounts Payables surged 191.34% in 2024 and plunged 66.7% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $4.0 million in 2022, then declined by 13.24% to $3.5 million in 2023, then jumped by 191.34% to $10.1 million in 2024, then increased by 2.06% to $10.3 million in 2025, then decreased by 10.53% to $9.2 million in 2026.
- Per Business Quant, the three latest SRRK Accounts Payables figures stand at $9.2 million (Q1 2026), $10.3 million (Q4 2025), and $6.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - | 9.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.22 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 4.44 Mn |
| Dec 31, 2024 | 10.10 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 3.32 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | 3.72 Mn |
| Dec 31, 2022 | 3.99 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Mar 31, 2022 | 2.99 Mn |
| Dec 31, 2021 | 4.43 Mn |
| Sep 30, 2021 | 2.04 Mn |
| Jun 30, 2021 | 1.63 Mn |